fda semaglutide warning november 2025 The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw FDA Decisions Expected: November 2025

Surgery may be a good option if you: Have a body mass index (BMI) of 35 or higher, or a BMI of 30 or higher with conditions like diabetes, high blood pressure, or sleep apnea Have not been able to achieve or maintain weight loss through diet, exercise or medication At Louisiana Center for Bariatrics, our surgeons use minimally invasive techniques to improve recovery times and long-term outcomes

Seguimiento: Todos los pacientes son supervisados de cerca por nuestros proveedores para garantizar la seguridad y la eficacia

Glutathione IV Infusion A full glutathione iv drip session that pairs the antioxidant with hydration for deeper wellness and brightening support

Reduz tambm a sensao de fome e a fadiga tpica das dietas baixas em calorias

How long should I try semaglutide before deciding it does not work

These findings could have major implications for healthy aging